Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Expert Opinion on Investigational Drugs
|
February 1, 2017
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma
Andrea Ferrario, Michele Merli, Claudia Basilico, et al.
Therapeutic Advances in Hematology
|
April 24, 2013
Novel agents in indolent lymphomas
Michele Merli, Andrea Ferrario, Claudia Basilico, et al.
Leukemia & Lymphoma
|
December 3, 2016
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion
Chiara Pessina, Claudia Basilico, Angelo Genoni, et al.
Hematological Oncology
|
June 4, 2014
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization
Giuseppe Rossi, Cristina Skert, Enrico Morello, et al.
Journal of Geriatric Oncology
|
October 24, 2020
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Cancers
|
January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
American Journal of Hematology
|
November 23, 2017
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
American Journal of Hematology
|
December 11, 2024
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial
Roberto Cairoli, Arianna Gatti, Giovanni Grillo, et al.
Cancer
|
August 21, 2025
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience
Roberto Cairoli, Lorenzo Del Castello, Silvia Imbergamo, et al.
Annals of Hematology
|
May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Luana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Expert Opinion on Investigational Drugs
|
February 1, 2017
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma
Andrea Ferrario, Michele Merli, Claudia Basilico, et al.
Therapeutic Advances in Hematology
|
April 24, 2013
Novel agents in indolent lymphomas
Michele Merli, Andrea Ferrario, Claudia Basilico, et al.
Leukemia & Lymphoma
|
December 3, 2016
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion
Chiara Pessina, Claudia Basilico, Angelo Genoni, et al.
Hematological Oncology
|
June 4, 2014
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization
Giuseppe Rossi, Cristina Skert, Enrico Morello, et al.
Journal of Geriatric Oncology
|
October 24, 2020
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Cancers
|
January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
Giuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
American Journal of Hematology
|
November 23, 2017
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
American Journal of Hematology
|
December 11, 2024
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial
Roberto Cairoli, Arianna Gatti, Giovanni Grillo, et al.
Cancer
|
August 21, 2025
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience
Roberto Cairoli, Lorenzo Del Castello, Silvia Imbergamo, et al.
Annals of Hematology
|
May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Luana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
Page
of 2